North West England MRC Fellowships in Clinical Pharmacology and Therapeutics

英格兰西北部 MRC 临床药理学和治疗学奖学金

• 批准号: G1000417/1
• 负责人: Munir Pirmohamed
• 金额: $ 214.64万
• 依托单位: University of Liverpool
• 依托单位国家: 英国
• 项目类别: Fellowship
• 财政年份: 2010
• 资助国家: 英国
• 起止时间: 2010 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=G1000417%2F1
• 关键词: North; West; England; MRC; Fellowships

In a recent report from the Office for Life Sciences, Clinical Pharmacology was highlighted asa specialty vital for healthcare and industry in the UK. Our proposed scheme builds upon ahighly successful training programme in Clinical Pharmacology, based at the University ofLiverpool. Our unique selling point is the collaboration between the Universities of Liverpooland Manchester based on the existing MRC Centre for Drug Safety Science, and with 2pharmaceutical companies (AstraZeneca and GlaxoSmithKline) and 2 contract researchorganisations (ICON and Medicines Evaluation Unit). We focus on important subject areas,including paediatrics, where there is a fundamental need to improve drugs for children. Thescheme is designed to identify the best students, provide them with ?without walls? trainingthrough attachments with our industry partners, together with excellent supervision andmentoring arrangements, all of which enhance the student learning experience. Over 4years, we will train 12 clinical fellows to undertake PhDs; each project will be tailored to theindividual and their clinical training. The Clinical Pharmacology skills base in the UK will beenhanced by the scheme with benefit to healthcare, academia, industry, regulation andultimately undergraduate training.

在生命科学办公室最近的一份报告中，临床药理学被强调为对英国医疗保健和工业至关重要的专业。我们建议的计划建立在利物浦大学一个非常成功的临床药理学培训计划的基础上。我们独特的卖点是利物浦大学和曼彻斯特大学之间的合作，该合作基于现有的MRC药物安全科学中心，并与2家制药公司(阿斯利康和葛兰素史克)和2家合同研究机构(ICON和药品评估单位)合作。我们专注于重要的学科领域，包括儿科，在这些领域，有必要改进儿童药物。该计划旨在识别最好的学生，为他们提供？没有围墙？通过与我们的行业合作伙伴进行附加培训，以及出色的监督和指导安排，所有这些都增强了学生的学习体验。在4年的时间里，我们将培训12名临床研究员来攻读博士学位；每个项目都将根据个人及其临床培训而量身定做。该计划将增强英国的临床药理学技能基础，有利于医疗保健、学术界、行业、监管以及最终的本科生培训。